This statistic represents the medicines in development for selected cancer types in the United States as of late 2020. At this moment, 141 medicines for lung cancer were in development. Thus, lung cancer was the type of cancer with one of the largest numbers of drugs in development.
Medicines in development for selected cancer types in the United States as of 2020*
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
PhRMA. (December 14, 2020). Medicines in development for selected cancer types in the United States as of 2020* [Graph]. In Statista. Retrieved May 16, 2022, from https://www.statista.com/statistics/248563/medicines-in-development-for-selected-cancer-types-in-the-us/
PhRMA. "Medicines in development for selected cancer types in the United States as of 2020*." Chart. December 14, 2020. Statista. Accessed May 16, 2022. https://www.statista.com/statistics/248563/medicines-in-development-for-selected-cancer-types-in-the-us/
PhRMA. (2020). Medicines in development for selected cancer types in the United States as of 2020*. Statista. Statista Inc.. Accessed: May 16, 2022. https://www.statista.com/statistics/248563/medicines-in-development-for-selected-cancer-types-in-the-us/
PhRMA. "Medicines in Development for Selected Cancer Types in The United States as of 2020*." Statista, Statista Inc., 14 Dec 2020, https://www.statista.com/statistics/248563/medicines-in-development-for-selected-cancer-types-in-the-us/
PhRMA, Medicines in development for selected cancer types in the United States as of 2020* Statista, https://www.statista.com/statistics/248563/medicines-in-development-for-selected-cancer-types-in-the-us/ (last visited May 16, 2022)
